Internal Medicine, Medical Oncology · Bethesda, MD
NPI
1003875295
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
6410 Rockledge Dr, Suite 660
Bethesda, MD, 20817
Phone (301) 571-0019
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.6M
369,095 services
Medicare patients, 2024
811
Average age 77
Drug cost, 2024
$4.3M
834 prescriptions
Company payments, 2025
$4,769
From 60 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Victor M Priego was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 114,700 times for 89 patients. In total Victor M Priego billed 369,095 services in 140 codes, and Medicare paid $5.6M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-03.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 114,700 | 89 | $2.31 | $265K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 16,900 | 112 | $15.73 | $266K |
| J0897 Injection, denosumab, 1 mg | Office | 4,560 | 27 | $20.31 | $93K |
| 85025 Blood Count | Office | 2,262 | 608 | $7.53 | $17K |
| 36415 Venipuncture Blood Collection | Office | 2,158 | 603 | $8.57 | $18K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,410 | 16 | $0.09 | $128 |
| 99213 Office E&M - Established | Office | 1,374 | 550 | $73.83 | $101K |
| 96372 Injection Administration | Office | 1,048 | 148 | $11.97 | $13K |
| 99214 Office E&M - Established | Office | 733 | 390 | $103.86 | $76K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 610 | 11 | $0.74 | $449 |
| 80053 Clinical Chemistry | Office | 576 | 314 | $10.33 | $5,952 |
| 96365 Intravenous Infusion, Hydration | Office | 358 | 153 | $53.75 | $19K |
| 82728 Clinical Chemistry | Office | 309 | 160 | $13.32 | $4,116 |
| 83540 Clinical Chemistry | Office | 306 | 159 | $6.32 | $1,934 |
| 96413 Chemotherapy Administration | Office | 288 | 33 | $117.50 | $34K |
By year: 2022 $4.2M for 457,442 services; 2023 $4.5M for 391,860 services; 2024 $5.6M for 369,095 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,262 | 608 | $7.53 | $17K |
| 36415 Venipuncture Blood Collection | 2,158 | 603 | $8.57 | $18K |
| 80053 Clinical Chemistry | 576 | 314 | $10.33 | $5,952 |
| 82728 Clinical Chemistry | 309 | 160 | $13.32 | $4,116 |
| 83540 Clinical Chemistry | 306 | 159 | $6.32 | $1,934 |
| 83615 Clinical Chemistry | 258 | 184 | $5.92 | $1,527 |
| 83550 Clinical Chemistry | 87 | 70 | $8.57 | $746 |
| 82378 Clinical Chemistry | 82 | 62 | $18.58 | $1,524 |
| 82232 Clinical Chemistry | 70 | 47 | $15.86 | $1,110 |
| 85045 Blood Count | 52 | 51 | $3.91 | $203 |
Medicare prescription drug claims, 2024
In 2024, the drug Victor M Priego prescribed most often to Medicare patients was Eliquis (Apixaban), with 97 prescriptions and refills. In total Victor M Priego wrote 834 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 97 | 181 | 27 | $100K |
| Xarelto Rivaroxaban | 91 | 188 | 22 | $102K |
| Letrozole Generic | 49 | 121 | 12 | $1,656 |
| Dexamethasone Generic | 45 | 58 | Under 11 | $667 |
| Revlimid Lenalidomide | 39 | 39 | Under 11 | $672K |
| Jakafi Ruxolitinib Phosphate | 32 | 32 | Under 11 | $550K |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 27 | 27 | Under 11 | $228K |
| Ibrance Palbociclib | 24 | 24 | Under 11 | $360K |
| Lenvima Lenvatinib Mesylate | 19 | 20 | Under 11 | $170K |
| Warfarin Sodium Generic | 17 | 46 | Under 11 | $157 |
| Gabapentin Generic | 16 | 16 | Under 11 | $295 |
| Hydroxyurea Generic | 16 | 35 | Under 11 | $270 |
| Tamoxifen Citrate Generic | 15 | 42 | Under 11 | $723 |
| Acyclovir Generic | 14 | 29 | Under 11 | $347 |
| Promacta Eltrombopag Olamine | 14 | 14 | Under 11 | $175K |
Brand drugs: 498 claims; generic drugs: 336 claims; opioid claims: 38.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Victor M Priego $4,769 ($4,769 in general payments such as food, travel and fees) from 60 companies. The largest payer was Janssen Biotech, Inc. with $441.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 17 | $441 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $371 |
| Pfizer Inc. PFE | 13 | $323 |
| Merck Sharp & Dohme LLC MRK | 10 | $264 |
| Daiichi Sankyo Inc. 4568.T | 7 | $178 |
| Incyte Corporation INCY | 8 | $177 |
| Exelixis Inc. EXEL | 4 | $132 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $131 |
| Eisai Inc. 4523.T | 2 | $124 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $115 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.